Ronald Witteles
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Daratumumab-SC for Highly Sensitized Patients Awaiting Heart Transplantation (NCT04610320) | Ronald Witteles | 2021-07-01 |
| Study of Daratumumab for Decreasing Circulating Antibodies in Sensitized Patients Awaiting Heart Transplantation (NCT04088903) | Ronald Witteles | 2021-04-01 |
Track Ronald Witteles automatically
Every clearance here is in the API, with alerts when new ones post.